IDRA-21, ≥ 99.0% purity. CAS No. 22503-72-6

IDRA-21 is a benzothiadizine compound with a unique heterocyclic structure that affects nerve signaling by regulating glutamate receptor function. The molecule has exhibited synaptic plasticity-enhancing effects in in vitro studies, and its stable chemical properties make it suitable for use as a scientific tool compound. 

Description

Product name IDRA-21
Other name
7-Chloro-3-methyl-3,4-dihydro-2H-1,2,4-benzothiadiazine-1,1-dioxide;IDRA 21
CAS No. 22503-72-6
Molecular formula C8H9ClN2O2S
Molecular Weight 232.69
Purity 99%

Features

(1) High selectivity: It has an effect on specific receptor subtypes.
(2) Stability: Stable chemical properties at room temperature.

Application

As an important scientific research tool compound, IDRA-21 has shown a wide range of application value in many fields due to its unique molecular properties. In the field of basic research, it is not only used for the discovery of molecular recognition mechanisms and organic synthesis intermediates (especially heterocyclic compound synthesis), but also as a standard to support the development of analytical detection methods. In terms of applied research, IDRA-21 plays a key role in biotechnology research such as functional material development and molecular probe construction. Of particular note is that experimental studies have shown that IDRA-21 can optimize nerve signaling, showing a potential effect on maintaining brain vitality, a property that allows it to optimize cognitive function and enhance memory performance.